These profitable, time-tested businesses could be your ticket to success during periods of heightened volatility.
Former “Bachelor” star Colton Underwood sat down with Robin Roberts on Wednesday morning for a deeply personal interview, revealing that he is gay. In the interview, Underwood, who is also a former pro football player, was very emotional in admitting the truths he learned about himself during quarantine. “Obviously this year’s been a lot for […]
The traditional approach to global freight management in the logistics industry faces challenges at every step due to process delays, product theft, and spoilage, lack of supply chain visibility, and resource limitations.New York, April 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "IoT-powered Digital Ecosystem Transforming the Global Logistics Industry" - https://www.reportlinker.com/p06058085/?utm_source=GNW Missteps and uninformed decisions in supply chain and logistics operation create havoc and translate into damaged customer relationships. Despite the challenges, the logistics industry continues to develop, as the industry has become truly global with a growing demand for eCommerce and increased customer expectations. The global logistics industry is fragmented in nature and operates at low margins with staff shortages in the commercial trucking and labor-intensive industry segments. The Internet of Things (IoT) is making waves in the supply chain and logistics sectors with the advent of digital technologies, and it holds the answer to several challenges because it can enable the logistics industry stakeholders to have agile and streamlined operations.IoT-as-a-solution has evolved a long way, and today, logistics is not just about freight movement and IoT-powered tracking solutions with sensor tags to understand the physical location of freight. Applications of IoT has progressed to accurate status updates about freight and resources involved, identification of operational bottlenecks, and isolation of logistics process delays and risks. With the emergence of 5G networks and artificial intelligence (AI) applications, IoT solutions enable stakeholders in the logistics industry to create efficiencies in their operations and deliver in-transit freight conditions and operating fleet details so they can execute effective remedial actions when required and ensure profitability and service innovation. The global maritime and container-line industry is focused on developing digital platforms for transparent pricing. However, a few industry leaders have been using IoT to digitize their physical infrastructures to offer a new generation of services. Resource safety management and sustainable business solutions have become the key industry focus areas, with IoT solutions. The road transportation sector, which relies on telematics to deliver connected assets for smart and integrated logistics operations, leads the race in terms of IoT adaption and optimisation. The connected logistics ecosystem with IoT devices with AI-powered cloud-based solutions creates an enormous impact on the end-to-end logistics value chain, delivering workaround insights for cost and resource optimization, to ensure effective disaster and risk management. This study analyses how the global logistics industry spends on IoT solutions. It provides regional market overviews and their respective shares, drivers, and adoption barriers and identifies key trends and application areas in the end-to-end logistics value chain. This study also identifies the new-generation services and transformational growth opportunities in a strategic partner ecosystem so that logistics industry participants can deliver future-proof connected solutions for smart logistics operation.Read the full report: https://www.reportlinker.com/p06058085/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
The annual general meeting of shareholders of Coop Pank AS (registry code 10237832, address Narva mnt 4, Tallinn, 15014; hereinafter the Company) was held on 14 April 2021 at 13:00 (Estonian time) at Tallinna Ülikool conference room “Maximum” (Narva mnt 29, Tallinn). 57 740 878 votes were represented at the meeting, representing 63,71% of Company's share capital, and thus the general meeting had a quorum. 57 shareholders were represented at the meeting. The decisions of the General Meeting were as follows: Approval of the consolidated Annual Report 2020 of Coop Pank AS. The general Meeting decided to approve consolidated Annual Report 2019 of Coop Pank AS submitted to the General Meeting. The resolution was adopted by 57 710 878 votes, representing 99,95% of the votes represented at the meeting. Profit allocation of Coop Pank AS 2020 financial year. The general Meeting decided to allocate the net profit of Coop Pank AS in the amount of 7 259 thousand euros as follows: allocate 363 thousand euros to statutory reserve capital;not to allocate profit in any other reserve prescribed by law or Articles of Association and not to use the profit for other purposes;not to pay dividend to shareholders and to allocate 6 896 thousand euros to retained earnings. The resolution was adopted by 57 708 478 votes, representing 99,94% of the votes represented at the meeting. Election of a new Member of Supervisory Board The General Meeting decided to appoint the following person to Supervisory Board: Viljar Arakas with authority as of the date of this decision for a term of 3 (three) years. The resolution was adopted by 57 688 478 votes, representing 99,91% of the votes represented at the meeting. An overview of the activities of the new member of the Supervisory Board during the previous 3 years is attached. The minutes of the general meeting shall be made available to the shareholders not later than within 7 (seven) days from the date of the general meeting at Company’s website https://www.cooppank.ee/en/for-investors . Based on Estonian´s capital, Coop Pank is one in five universal banks operating in Estonia. Coop Pank’s banking services are used by more than 90,900 clients. Coop Pank AS uses the synergies between retail and banking and brings everyday banking services closer to home. The strategic owner of the bank is the domestic retail chain Coop Eesti, whose sales network includes 330 stores. Additional information:Kerli LõhmusCFOPhone: +372 669 0902E-mail: firstname.lastname@example.org Annex: Information on the supervisory board member Attachment Annex_Information on the supervisory board member_ENG
Goldman is preparing for "a world beyond the pandemic," as its first quarter results set a record.
Stock futures pointed to another mixed session on Wall Street, with traders digesting a slew of earnings results from big banks.
Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Global Plastic Injection Molding Machine Market by Type (Hydraulic, All-Electric, Hybrid), Clamping Force (0-200, 201-500, Above 500 Tons Force), End-use Industry, and Region - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The global plastic injection molding machines market is estimated at USD 8.9 billion in 2020 and is projected to reach USD 10.6 billion by 2025, at a CAGR of 3.61%. Plastic molds are widely used in the healthcare industry. Plastic injection molding machines are preferred for manufacturing medical products, as these machines offer high precision, accurate, and complex injection molded parts. These machines have application in surgical and medical devices such as syringes, vials, medical instruments, inhalers, cannulated, medicinal connectors, air systems, and prescription bottles. The outbreak of coronavirus across the globe has highlighted the healthcare industry. Due to explosive surge in the number of Covid-19 cases, the demand for medical equipment like syringes, air systems, and other medical instruments increased exponentially. Countries such as India and China became the hub for manufacturing and meeting the demand for all these equipment across the globe. 201-500 Tons Force is projected to grow at highest CAGR, by clamping force, during the forecast period The 201-500 ton-force segment accounted for the largest market share in terms of value, in 2019 and is projected to register the highest CAGR during the forecast period. This high growth is attributed to the rising demand for medium-sized molded parts from major end-use industries such as automotive, packaging, and consumer goods. The clamping force of 201-500 ton-force is mainly used in medium-sized plastic injection molding machines. Machine types such as hydraulic, all-electric, and hybrid are available in 201-500 ton-force. These machines are mainly used for applications in the automotive, packaging, and consumer goods industries, where relatively medium-sized molded parts are required. Hydraulic injection molding machine is the largest machine type for plastic injection molding machine market in 2019 Hydraulic injection molding machine is the most popular machine type, primarily because of its long service life and a wide range of applications. The hydraulic injection molding machine consists of a fixed-speed, three-phase motor, and a variable-volume pump. Hydraulic injection molding machines have a long life, far drive distance, and low maintenance cost. This type of machine helps in significant reduction of production cycle time. Molders mainly use high-tonnage hydraulic machines for molding large parts. This machine is mainly used for producing high precision plastic components such as automotive parts, caps & closers, consumer goods, electrical & electronics goods, and medical items. Automotive is estimated to be the largest end-use industry in plastic injection molding machine market between 2020 and 2025 Plastic injection molding machines are predominantly used in manufacturing automotive components, interior wrapping, and assembly parts, such as automotive exteriors, car lenses, interior components, under-the-hood components, and filter components. A strong shift in the use of plastics instead of iron and steel in the automotive industry is expected to drive the plastic injection molding machine market during the forecast period. Stringent government regulations have forced automotive manufacturers to use plastics instead of other materials such as iron and steel. Rapid economic growth, improved infrastructure, and rising middle-class population in emerging economies have led to an increase in vehicle production and sales, which, in turn, increase the demand for plastic injection molding machines. The rapidly growing automotive industry in APAC is also one of the major factors driving the plastic injection molding machine market. APAC is expected to be the largest plastic injection molding machine market during the forecast period, in terms of value and volume The APAC comprises major emerging nations such as China and India. Hence, the scope for the development of most industries is high in this region. The plastic injection molding machine market is growing significantly and offers opportunities for various manufacturers. The APAC region constitutes approximately 61% of the world's population, and the manufacturing and processing sectors are growing rapidly in the region. The APAC is the largest plastic injection molding machine market with China being the major market which is expected to grow significantly. The rising disposable incomes and rising standards of living in emerging economies in the APAC are the major drivers for this market. The increasing population in the region accompanied with development of new technologies and products are projected to make this region an ideal destination for the growth of the plastic injection molding machine market. However, establishing new plants, implementing new technologies, and creating a value supply chain between raw material providers and manufacturing industries in the emerging regions of the APAC are expected to be a challenge for industry players as there is low urbanization and industrialization. Booming automotive, consumer goods and packaging sectors and advances in process manufacturing are some of the key drivers for the market in the APAC. Countries such as India, Indonesia, and China are expected to witness high growth in the plastic injection molding machine market due to the increasing demand from the automotive industry. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights4.1 Attractive Market Opportunities for Plastic Injection Molding Machine Manufacturers4.2 APAC Plastic Injection Molding Machine Market, by Type and Country4.3 Plastic Injection Molding Machine Market, by Region4.4 Plastic Injection Molding Machine Market, by Region and Machine Type4.5 Plastic Injection Molding Machine Market, by Key Countries 5 Market Overview5.1 Introduction5.2 Market Dynamics5.2.1 Drivers22.214.171.124 High Demand from the Packaging Industry126.96.36.199 Rising Awareness About Energy Saving188.8.131.52 Growth in Automotive Sector Fueling Demand for Large Plastic Molds184.108.40.206 New Developments in Plastic Injection Molding Technology5.2.2 Restraints220.127.116.11 High Initial and Maintenance Cost of Machines5.2.3 Opportunities18.104.22.168 Growing Demand from Healthcare Industry22.214.171.124 Growing Demand for Large-Tonnage Plastic Injection Molding Machines126.96.36.199 Rising Trend of Electric Vehicles to Increase Demand for Plastic Injection Molds5.2.4 Challenges188.8.131.52 High Heating and Hydraulic Pressure184.108.40.206 Less Economical for Small Production Capacities5.3 Technology Overview5.4 Porter's Five Forces Analysis5.4.1 Threat of Substitutes5.4.2 Threat of New Entrants5.4.3 Bargaining Power of Suppliers5.4.4 Bargaining Power of Buyers5.4.5 Intensity of Competitive Rivalry5.5 Macroeconomic Indicators5.5.1 GDP Trends and Forecast of Major Economies5.6 COVID-19 Impact5.6.1 Introduction5.6.2 COVID-19 Health Assessment5.6.3 COVID-19 Economic Assessment220.127.116.11 COVID-19 Impact on the Economy - Scenario Assessment5.7 Impact of COVID-19: Customer Analysis 6 Industry Trends6.1 Supply Chain Analysis6.1.1 Raw Materials6.1.2 Manufacturing of Plastic Injection Molding Machines6.1.3 Distribution to End-user6.2 Plastic Injection Molding Machine Market: Realistic, Pessimistic, Optimistic, and Non-COVID-19 Scenario6.2.1 Non-COVID-19 Scenario6.2.2 Optimistic Scenario6.2.3 Pessimistic Scenario6.2.4 Realistic Scenario6.3 Shift in Revenue Streams due to Megatrends in End-use Industries6.4 Connected Markets: Ecosystem6.5 Case Studies6.6 Trade Data Statistics6.7 Average Selling Price6.8 Regulatory Landscape6.8.1 Regulations Related to Plastic Injection Molding Machine6.9 Patent Analysis6.9.1 Introduction6.9.2 Methodology6.9.3 Document Type6.9.4 Insight6.9.5 Jurisdiction Analysis6.9.6 Top Applicants 7 Plastic Injection Molding Machine Market, by Machine Type7.1 Introduction7.2 Hydraulic Injection Molding Machine7.3 All-Electric Injection Molding Machine7.4 Hybrid Injection Molding Machine 8 Plastic Injection Molding Machine Market, by End-use Industry8.1 Introduction8.2 Automotive8.3 Consumer Goods8.4 Packaging8.5 Healthcare8.6 Electrical & Electronics8.7 Others 9 Plastic Injection Molding Machine Market, by Clamping Force9.1 Introduction9.2 0-200 Ton-Force9.3 201-500 Ton-Force9.4 Above 500 Ton-Force 10 Plastic Injection Molding Machine Market, by Region10.1 Introduction10.2 APAC10.3 Europe10.4 North America10.5 Middle East & Africa10.6 South America 11 Competitive Landscape11.1 Introduction11.2 Market Evaluation Framework11.3 Ranking Analysis of Key Market Players, 201911.4 Market Share of Key Players11.4.1 Haitian International Holdings Limited11.4.2 Chen Hsong Holdings Limited11.4.3 Engel Austria GmbH11.4.4 Sumitomo Heavy Industries Limited11.4.5 Hillenbrabd, Inc. (Milacron Holdings Corp.)11.5 Company Product Footprint Analysis11.6 Company Evaluation Matrix (Tier 1)11.6.1 Terminology/Nomenclature18.104.22.168 Star22.214.171.124 Emerging Leader11.6.2 Strength of Product Portfolio11.6.3 Business Strategy Excellence11.7 Start-Up/SME Evaluation Matrix11.7.1 Terminology/Nomenclature126.96.36.199 Responsive Companies188.8.131.52 Dynamic Companies184.108.40.206 Starting Blocks11.7.2 Strength of Product Portfolio11.7.3 Business Strategy Excellence11.8 Revenue Analysis of Major Players, 2015-201911.9 Competitive Situations and Trends11.9.1 Product Launches11.9.2 Deals11.9.3 Other Developments 12 Company Profiles12.1 Major Players12.1.1 Haitian International Holdings Limited220.127.116.11 Business Overview18.104.22.168 Products Offered22.214.171.124 Recent Developments126.96.36.199 Winning Imperatives188.8.131.52 SWOT Analysis184.108.40.206 Current Strategies220.127.116.11 Right to Win12.1.2 Sumitomo Heavy Industries Limited12.1.3 The Japan Steel Works Ltd.12.1.4 Chen Hsong Holdings Limited12.1.5 Hillenbrand, Inc.12.1.6 Engel Austria GmbH12.1.7 Arburg GmbH & Co. KG12.1.8 Nissei Plastic Industrial Co. Ltd.12.1.9 Husky Injection Molding Systems Ltd.12.1.10 Kraussmaffei Group GmbH12.1.11 Dongshin Hydraulic Co. Ltd.12.2 Startups/SME Players12.2.1 Niigata Machine Techno Company, Ltd.12.2.2 Huarong Plastic Machinery Co. Ltd.112.2.3 Fu Chun Shin Machinery Manufacture Co. Ltd.12.2.4 Shibaura Machine (Toshiba Machine Co. Ltd.)12.2.5 Oima Srl12.2.6 R.P. Injection Srl12.2.7 Toyo Machinery & Metal Co. Ltd.12.2.8 Boco Pardubice Machines S.R.O.12.2.9 Mitsubishi Heavy Industries Plastic Technology Co. Ltd.12.2.10 Woojin Plaimm Co. Ltd.12.2.11 Borche North America Inc.12.2.12 Multiplas Enginery Co. Ltd.12.2.13 Mold Hotrunner Solutions Ltd.12.2.14 Dr. Boy GmbH & Co. KG12.2.15 SMF Maschinenfabrik GmbH 13 Adjacent and Related Markets13.1 Introduction13.2 Limitations13.3 Molded Plastics Market13.3.1 Market Definition13.3.2 Market Overview13.3.3 Molded Plastics Market, by Type18.104.22.168 Polyethylene22.214.171.124 Polypropylene126.96.36.199 Polyvinyl Chloride188.8.131.52 Polyethylene Terephthalate184.108.40.206 Polystyrene220.127.116.11 Polyurethane18.104.22.168 Others 14 Appendix14.1 Discussion Guide14.2 Knowledge Store: The Subscription Portal14.3 Available Customizations For more information about this report visit https://www.researchandmarkets.com/r/f7123c CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The "Data Monetization Drives Innovative Business Models in the Global MedTech Industry" report has been added to ResearchAndMarkets.com's offering.
When Tina Sheridan started her business a decade ago, she didn’t expect it would grow into what it is today. Sheridan is the president of CreeQuest Corp., a regional Indigenous business providing catering, janitorial and laundry services as well as drilling exploration. CreeQuest recently announced its renewed partnership with Aramark Canada to continue providing Kirkland Lake Gold's Detour Lake Mine with catering and janitorial services. The companies started partnering in 2013. At the mine, CreeQuest and Aramark employ 50.5 per cent women and about 40 to 48 per cent Indigenous people. Through all its partnerships, CreeQuest employs about 120 people. The company developed a recruitment and retention strategy and recently hired a lead recruiter, Jaimie Sutherland, who will be working with partners to maximize employment opportunities and provide guidance to Indigenous job seekers. “We commit ourselves 100 per cent to the business. When we work with partners, we’re at the same table. We help make decisions, we understand the day-to-day operations. We’re not in the back seat, we’re upfront with everybody else,” Sheridan said. Sheridan's company started off as a side business offering catering services at community events and business meetings with a traditional twist to the food. “That set the pace for joining up with the major catering company, Aramark,” Sheridan said. “Right away, we started to bid on bigger contracts, and it wasn’t something I could do alone. I didn’t have the equipment, I didn’t have as much knowledge as I have today. The idea of having a partner to learn the industry was ideal.” What prompted Sheridan, who is a Taykwa Tagamou Nation member, to start a business was a need to make extra money. At the time, as a mother of two, she just finished a four-year term as a band councillor and was completing her high school diploma with the Indigenous Adult Alternative Education Program (IAAEP). Sheridan credits her former teacher Michelle Durant-Dudley for sparking her confidence at the time. Years later, CreeQuest and Aramark became one of the major funders of the IAAEP program. In May 2020, the business was incorporated and from a sole proprietorship, it turned into a regional Indigenous business. Moose Cree First Nation member Greg Sutherland and Wahgoshig First Nation member Virginia Forsythe joined the company as shareholders and owners. The three of them had already crossed paths on different projects before, according to Sutherland. “So far, it’s been really, really great,” Sutherland said. “One of my goals is to ensure that our Indigenous people are involved at a higher end being hired to positions. Essentially, we had the same vision and we’re working towards that vision to have as many Indigenous people hired as possible on the contract that we have.” For Forsythe, providing employment and business opportunities from her reserve has been great. “We’re all on the same page,” she said. “We just want to be very successful and help out communities in any way we can whether it’s training other First Nations on how to go about being a company like ours.” Some of the other CreeQuest’s partners include Komplete Modular Solutions Ltd. and NPLH Drilling. When the company is successful in winning a contract, the owners set aside a certain percentage toward the so-called First Nation fund and another percentage for equipment. The remaining balance is used to keep CreeQuest operating. “The equipment fund is structured for building capacity for CreeQuest. If there was a project down the road that required equipment, we would have our own money to buy our own equipment. The First Nation fund is what we built up to give towards the communities,” Sheridan said. Being able to give back to the communities and seeing a new infrastructure or a program continue to run thanks to their contributions is gratifying, Sheridan said. Before CreeQuest incorporated, Sheridan made a donation to help build a basketball court in Wahgoshig. According to Sheridan, the biggest challenges during her experience owning a company have been people not understanding the time it takes to build a small business, maintaining relationships and creating new ones where she would be taken seriously. Coming from a “humble background” and having those experiences made her want to work hard and be successful, Sheridan said. “As an Indigenous woman, it could be quite intimidating. It was intimidating in the early years sitting at the table with people who had a mount of education and certificates and not understanding if I was at the right place,” she said. “But over time, I earned my spot and I’m much more confident now.” In the next few weeks, there will be an announcement for a community investment project and a new website will be launched, according to Sheridan. The corporation's future goals are to expand CreeQuest into a full mining services company, continue developing meaningful and sustainable partnerships and keeping their home communities at the “forefront of importance”, Sheridan said. What’s also important for the company is its legacy. “Long after we’re gone, our work will still continue to, hopefully, provide an impact down the road,” she said. Dariya Baiguzhiyeva, Local Journalism Initiative Reporter, TimminsToday.com
Britain's biggest aerospace employers, including Rolls-Royce Holdings and Airbus, have urged the business secretary to step into the crisis engulfing the steel tycoon Sanjeev Gupta amid fears of a global shortage of specialist materials. Sky News has learnt that the industry association ADS has written to Kwasi Kwarteng to highlight its members' reliance on the specialist steels produced by Mr Gupta's GFG Alliance group at its UK plants. In the letter, which was sent last week by the ADS interim chief executive Kevin Craven, Mr Kwarteng was told that the industry had become deeply concerned about the continuity of steel supply required for its members' engineering and manufacturing operations to continue.
Sir James Dyson defends moving his firm's headquarters to Singapore and says Dyson is a British firm.
The football player-turned-reality TV star made the announcement on Good Morning America.
TORONTO — Two health networks in Toronto say shortages of COVID-19 vaccine are forcing them to limit or close immunization clinics. Scarborough Health Network says it will be closing its Centennial College and Centenary hospital clinics today. University Health Network says it has had to pause registration for appointments for adults over 18 who qualify for vaccination based on their postal code. Both organizations say they will reopen their clinics as soon as they receive more vaccines. The networks say they are contacting everyone whose vaccination appointment was cancelled by the supply shortage and will rebook appointments as soon as possible. The clinics run by Scarborough Health Network were vaccinating local residents over the age of 50, all Indigenous adults, and health-care workers. Others eligible for the vaccine at the closed Scarborough locations are chronic home care clients, faith leaders, and people over 18 with high-risk health conditions. This report by The Canadian Press was first published April 14, 2021. The Canadian Press
With the advent of digitization in healthcare, all industry efforts are geared toward better leveraging this stream of digital data to achieve the goals of precision medicine and precision health. The amount of health data that is becoming available is increasing exponentially each year, with new sources, such as wearable devices and social determinants of health, making such data accessible for care delivery improvement.New York, April 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Data Monetization Drives Innovative Business Models in the Global MedTech Industry" - https://www.reportlinker.com/p06058082/?utm_source=GNW It is estimated that the healthcare industry generated over 2,000 exabytes (1 exabyte = 10,002 Terabytes) of data in 2020. The question is how can we monetize this data?For data monetization, healthcare is a unique industry due to two reasons. First, the issues of privacy are more complex in healthcare, governed by an increasingly complicated set of regulations.Second, the source of the data is almost always a patient, but where it is generated (care delivery location, a clinical trial, or academic research), who uses it (physicians, nurses, hospitals, payers, pharmaceutical companies, or MedTech companies), and for what use case (improving care delivery, personalizing medicine, drug/device R&D, or lowering costs) are completely different from other industries. In this study, we explain the difference between direct and indirect data monetization, how it applies to the healthcare industry and specifically the MedTech sector, provide a framework for MedTech companies to assess the data monetization potential for each of their products, and give examples of monetization for medical devices, surgical equipment, imaging equipment, prostheses and implants, and consumables, along with a final strategic decision-making checklist for MedTech companies to monetize their own data.Read the full report: https://www.reportlinker.com/p06058082/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
The Bachelor‘s Colton Underwood is setting the record straight about his sexuality: Yep, he’s gay. In an interview with Good Morning America‘s Robin Roberts that aired on Wednesday, Underwood — who headlined Season 23 of the ABC reality juggernaut — confirmed the longstanding rumor. ‘I’ve ran from myself for a long time, hating myself for a […]
Labour leader Sir Keir Starmer hit out at the ‘return of Tory sleaze’ over the Greensill controversy.
The "Maintaining Brand Loyalty as Digital Channels Thrive Amidst the COVID-19 Pandemic" report has been added to ResearchAndMarkets.com's offering.
Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Leukapheresis Market by Product (Devices, Filters, Columns, Disposables), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple Myeloma), Application (Research, Therapeutic), End User (Hospitals, Pharma, Biotech) - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. The global leukapheresis products market is projected to reach USD 91 million by 2026 from USD 61 million in 2021, at a CAGR of 8.4% during the forecast period. The leukopaks market is expected to reach USD 662 million by 2026, at a CAGR of 41.9%. Leukopaks are enriched leukapheresis products that contain higher concentrations of leukocytes. The increasing incidence and prevalence of leukemia and the growing demand for leukopaks for research applications are some of the factors driving the growth of these markets. However, the high cost of therapeutic leukapheresis and cellular therapies, stringent donor recruitment criteria, and long procedural time for leukapheresis are restraining the growth of this market to a certain extent. The leukapheresis disposables segment holds the highest market share, by product, in the leukapheresis products market, in the forecast period. On the basis of product, the leukapheresis market is broadly segmented into leukapheresis disposables and leukapheresis devices. Leukapheresis devices are further segmented into centrifugal devices and membrane separators. The large share of the leukapheresis disposables segment can be attributed to the recurrent use of disposables during leukapheresis procedures, increasing adoption of leukapheresis products for the collection of leukopaks and isolated PBMCs from leukopaks for research applications, and the increasing adoption of therapeutic leukapheresis procedures. The centrifugal devices segment to grow at the highest CAGR in the leukapheresis devices market, in the forecast period. Based on type, the leukapheresis devices market is broadly segmented into centrifugal devices and membrane separators. Centrifugal devices segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the increasing installation of centrifugal apheresis devices in hospitals for therapeutic apheresis. Increasing adoption of leukapheresis products for the development of cell-based immunotherapies to promote the growth of this segment in the forecast period. Based on application, the leukapheresis products market is segmented into research and therapeutic applications. The research applications segment accounted for the largest share of the leukapheresis products market during the forecast period. The large share of this segment is attributed to the increasing adoption of leukapheresis products for the development of cell-based immunotherapies and leukapheresis-derived primary cells in drug development. In the leukapheresis products market by end-user segment, blood component providers & blood centers segment holds the highest market share On the basis of end-user, the leukapheresis products market is segmented into blood component providers & blood centers, academic and research institutes, pharmaceutical & biotechnology companies, hospitals & transfusion centers. Blood component providers & blood centers hold the largest share in this market. The large share of this segment can be attributed to the growing demand for leukopaks for the development of CAR T-cell therapies, and the increasing demand for blood components in clinical conditions such as cancer. In the leukopaks market by type, the diseased leukopaks segment is projected to grow at the highest rate in the forecast period Based on type, the leukopaks market is segmented into mobilized leukopaks, non-mobilized leukopaks, diseased leukopaks, and isolated PBMCs. In this segment, the diseased leukopaks segment is projected to register the highest growth during the forecast period. The increasing demand for diseased-state leukopaks for cell interaction studies, drug toxicity studies, preclinical development of cell-based therapeutics, immunotherapy, immune-oncology studies, and regenerative medicine is driving the growth of this segment. Acute Lymphocytic Leukemia holds the largest share in the leukopaks market, by indication, in the forecast period Based on indication, the leukopaks market is segmented into acute lymphocytic leukemia, chronic lymphocytic leukemia, non-Hodgkin's lymphoma, multiple myeloma, hepatocellular carcinoma, pancreatic cancer, and other indications (colorectal cancer, neuroblastoma, breast cancer, and acute myeloid leukemia). The acute lymphocytic leukemia segment accounts for the largest share of the leukopaks market, by indication. The large share of this segment can be attributed to the increasing focus of pharmaceutical companies on the development of leukopak-based cell therapies for the treatment of acute lymphocytic leukemia (ALL) and a high number of CAR T-cell therapy clinical trials for ALL. Mobilized Lymphocytic Leukemia holds the largest share in the leukopaks market, by indication, in the forecast period Based on indication, the leukopaks market is segmented into mobilized leukopaks, non-mobilized leukopaks, diseased leukopaks, and isolated PBMCs. In this segment, the diseased leukopaks segment is projected to register the highest growth during the forecast period. The increasing demand for diseased-state leukopaks for cell interaction studies, drug toxicity studies, preclinical development of cell-based therapeutics, immunotherapy, immune-oncology studies, and regenerative medicine is driving the growth of this segment. The pharmaceutical and biotechnology companies segment to grow at the highest CAGR in the leukopaks market, by end-user, in the forecast period By end-user, the leukopaks market is segmented into pharmaceutical & biotechnology companies, contract research organizations, and academic & research institutes. Pharmaceutical and biotechnology companies are projected to grow at the highest CAGR in this market in the forecast period. The highest growth rate can be attributed to the increasing collaboration of pharmaceutical companies with academic institutes, research centers, and hospitals for new drug development. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights4.1 Leukapheresis Products Market Overview4.2 North America: Leukapheresis Products Market, by Type and Country4.3 Leukapheresis Products Market: Geographic Mix4.4 Regional Mix: Leukapheresis Products Market4.5 Leukopaks Market Overview4.6 North America: Leukopaks Market, by Product and Country4.7 Leukopaks Market: Geographic Mix4.8 Regional Mix: Leukopaks Market 5 Market Overview5.1 Introduction5.2 Market Dynamics5.2.1 Market Drivers22.214.171.124 Increasing Incidence and Prevalence of Leukemia126.96.36.199 Increasing Number of Blood Donations188.8.131.52 Demand for Leukopaks in Clinical Research5.2.2 Market Restraints184.108.40.206 High Cost of Therapeutic Leukapheresis and Leukopaks220.127.116.11 Stringent Donor Recruitment Criteria18.104.22.168 Dearth of Skilled Professionals and Low Adoption of Therapeutic Leukapheresis22.214.171.124 Complications Associated with Therapeutic Leukapheresis126.96.36.199 Long Procedural Time for Leukapheresis188.8.131.52 High Cost of Cellular Immunotherapies & Lack of Favorable Reimbursement5.2.3 Market Opportunities184.108.40.206 Leukapheresis for Pediatric Patients220.127.116.11 Emerging Economies and Increasing Investments from Academic Institutes, Pharma-Biotech Companies, and Leading Players5.2.4 Market Challenges18.104.22.168 Blood Transfusion Safety in Developing Countries5.3 Porter's Five Forces Analysis5.3.1 Threat from New Entrants5.3.2 Threat from Substitutes5.3.3 Bargaining Power of Suppliers5.3.4 Bargaining Power of Buyers5.3.5 Intensity of Competitive Rivalry5.4 Leukopaks: Pricing Analysis5.5 Regulatory Analysis (Leukapheresis Products Market)5.5.1 North America22.214.171.124 US126.96.36.199 Canada5.5.2 Europe5.5.3 Asia-Pacific188.8.131.52 Japan5.6 Regulatory Analysis (Leukopaks Market)5.7 Value Chain Analysis5.8 Ecosystem Map5.9 Patent Analysis5.10 Technology Analysis 6 Industry Insights6.1 Introduction6.2 Industry Trends6.2.1 Increasing Number of Collaborations Among Pharma and Biotech Companies6.2.2 Introduction of Customizable Cryopreserved Leukopaks6.2.3 Use of Leukapheresis in Clinical Trials to Determine Changes in Cellular Immune Profiles in COVID-19 Infections 7 Leukapheresis Products Market, by Type7.1 Introduction7.2 Leukapheresis Disposables7.2.1 Recurrent Usage and Demand for Disposables Boosting the Growth of this Segment7.3 Leukapheresis Devices7.3.1 Centrifugal Devices184.108.40.206 Increasing Installation of Centrifugal Apheresis Devices in Hospitals for Therapeutic Apheresis to Drive Market Growth7.3.2 Membrane Separators220.127.116.11 Difficulties in Separating Huge Volumes of Plasma from Milliliters of Whole Blood-A Key Factor Limiting the Adoption of These Devices 8 Leukapheresis Products Market, by Application8.1 Introduction8.2 Research Applications8.2.1 Increasing Number of Clinical Trials to Drive the Growth of this Segment8.3 Therapeutic Applications8.3.1 Increasing Adoption of Leukapheresis Procedures as a Supportive Treatment in Leukemia to Drive Market Growth 9 Leukapheresis Products Market, by End-user9.1 Introduction9.2 Blood Component Providers & Blood Centers9.2.1 Blood Component Providers & Blood Centers Are the Largest End-users of Leukapheresis Products9.3 Academic & Research Institutes9.3.1 Collaborations Between Pharmaceutical Companies and Academic & Research Institutes Will Drive Market Growth9.4 Pharmaceutical & Biotechnology Companies9.4.1 Increasing Number of Clinical Trials to Drive the Growth of this End-User Segment9.5 Hospitals & Transfusion Centers9.5.1 Growth in the Number of Hospitals Performing Transfusion to Drive Market Growth 10 Leukopaks Market, by Type10.1 Introduction10.2 Mobilized Leukopaks10.2.1 Mobilized Leukopaks Accounted for the Largest Share of the Market10.3 Non-Mobilized Leukopaks10.3.1 Low Cost as Compared to Mobilized Leukopaks to Drive Market Growth10.4 Diseased Leukopaks10.4.1 Rising Adoption of Diseased Leukopaks for Cell Interaction and Drug Toxicity Studies to Drive Market Growth10.5 Isolated Pbmcs10.5.1 Increasing Focus of Researchers on Cell-Based Therapies to Drive Market Growth 11 Leukopaks Market, by Indication11.1 Leukopaks Market, by Indication 12 Leukopaks Market, by End-user12.1 Introduction12.2 Academic & Research Institutes12.2.1 Increasing Number of Industry-Academic Partnerships for Conducting Research on Cell-Based Cancer Therapies to Drive Market Growth12.3 Pharmaceutical & Biotechnology Companies12.3.1 Rising Demand for Target Drug Development Utilizing Leukopaks as Starting Material to Drive Market Growth12.4 Contract Research Organizations12.4.1 Increasing Sponsorship of Clinical Trials to Drive the Growth of this End-User Segment 13 Geographic Analysis13.1 Introduction13.2 North America13.3 Europe13.4 Asia-Pacific13.5 Rest of the World 14 Competitive Landscape14.1 Introduction14.2 Revenue Share Analysis of the Top 4 Market Players14.3 Product Footprint Analysis of the Top Players in the Leukapheresis and Leukopaks Markets14.4 Leukapheresis Market Share (2020)14.5 Leukopaks Market Share (2020)14.6 Competitive Leadership Mapping (Leukapheresis Market)14.7 Company Evaluation Matrix Definition & Methodology14.7.1 Stars14.7.2 Emerging Leaders14.7.3 Pervasive Players14.7.4 Participants14.8 Competitive Leadership Mapping for Start-Ups (Leukapheresis Market) (2020)14.8.1 Progressive Companies14.8.2 Dynamic Companies14.8.3 Starting Blocks14.8.4 Responsive Companies14.9 Competitive Leadership Mapping (Leukopaks Market)14.9.1 Stars14.9.2 Emerging Leaders14.9.3 Pervasive Players14.9.4 Participants14.10 Competitive Situations and Trends 15 Company Profiles15.1 Key Players (Leukapheresis Market)15.1.1 Asahi Kasei Corporation15.1.2 Fresenius Se & Co. Kgaa15.1.3 Haemonetics Corporation15.1.4 Terumo BCT15.1.5 Macopharma Sa15.1.6 Miltenyi Biotec15.2 Other Players (Leukapheresis Market)15.2.1 Guangzhou Daji Medical Science and Technology Co. Ltd.15.2.2 Medica Spa.15.2.3 Puriblood Medical Co. Ltd.15.2.4 Beijing Zksk Technology Co. Ltd.15.3 Key Players (Leukopaks Market)15.3.1 Allcells, LLC15.3.2 Stemexpress, LLC15.3.3 Charles River Laboratories International, Inc.15.3.4 Lonza Group Ag15.4 Other Players (Leukopaks Market)15.4.1 Caltag Medsystems Limited15.4.2 Zenbio, Inc.15.4.3 Precision for Medicine, Inc.15.4.4 Bioivt15.4.5 Discovery Life Sciences15.4.6 Intelligent Tissue Group 16 Appendix16.1 Discussion Guide16.2 Knowledge Store: Subscription Portal16.3 Available Customizations16.4 Related Reports16.5 Author Details For more information about this report visit https://www.researchandmarkets.com/r/5myqq6 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The House Ethics Committee had been investigating charges the Kansas City-area Republican abused his children more than a decade ago.
Wall Street will be focused on Coinbase Wednesday with the digital currency exchange becoming a publicly traded company. Coinbase is making its initial public offering of stock with cryptocurrency chatter seemingly everywhere, even at the U.S. Federal Reserve. It is being incorporated into the business plans and accepted by major corporations like Tesla, PayPal and Visa. “The Coinbase IPO is potentially a watershed event for the crypto industry and will be something the Street will be laser focused on to gauge investor appetite,'" Wedbush analyst Daniel Ives wrote this week. There were 43 million verified Coinbase users in 2020, with 2.8 million making transactions monthly. Its revenue more than doubled to $1.14 billion last year and the company swung to a profit of $322.3 million after losing tens of millions in 2019. When Coinbase filed papers with U.S. regulators in February to go public, it said it would do so through a direct listing, which allows insiders and early investors to convert their stakes in the company into publicly traded stock. Shares of Coinbase, which will be traded on the Nasdaq under the ticker “COIN,' will attract investors who want to get into the cryptocurrency space in addition to, or without buying any coins at all, said Lule Demmissie, president of Ally Invest. “It could also be a less volatile security than the coins themselves,” Demmissie says. Some Wall Street analysts project that Coinbase Global Inc. could be valued at $100 billion, based on private transactions of its shares. This week Nasdaq gave the company a $250 reference price. That would make it one of the top 100 biggest publicly traded U.S. companies that will be far larger than the New York Stock Exchange or Nasdaq. The Coinbase hype went into overdrive last week when the company reported estimates of its first-quarter results, including about $1.8 billion in revenue and net income between $730 million and $800 million. Still, not everyone is convinced. David Trainer, CEO of investment research firm New Constructs, said Coinbase has “little-to-no-chance of meeting the future profit expectations that are baked into its ridiculously high valuation.” Trainer last week put a valuation on Coinbase closer to $18.9 billion, arguing it will face more competition as the cryptocurrency market matures. However Ives, of Wedbush, sees Coinbase as a window into the future. “Coinbase is a foundational piece of the crypto ecosystem and is a barometer for the growing mainstream adoption of Bitcoin and crypto for the coming years," Ives said. Michelle Chapman And Alex Veiga, The Associated Press
Keir Starmer says the revelations of ex-PM’s lobbying of Cabinet ministers has exposed ‘sleaze at the heart of this Conservative government’